经过横导管边缘到边缘修复后,中枢梯度升高:有通过裂掉落的风险. 叙事评审是对叙事进行的评审
1Colegio Mexicano de Cirugía Cardiovascular y Torácica, Mexico City, Mexico.
概括
跨导管边缘到边缘的修复是严重的 mitrale 吐的范式转变. 然而,术后高转移梯度对死亡率和发病率的长期影响仍在争论中.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
背景情况:
- 在高风险患者中,跨导管端到端修复 (TEER) 提供了一种对严重的额叶吐 (MR) 不那么侵入性的选择.
- 该程序涉及将一个剪贴贴在近似的 mitra 门传单上,旨在减少 MR.
- 人们还担心,术后转移梯度升高的长期后果.
研究的目的:
- 审查TEER后升高的传导梯度的影响.
- 为了分析残留MR减少和中枢梯度增加之间的权衡.
- 为围绕TEER结果的复杂性和正在进行的辩论提供全面的概述.
主要方法:
- 文献综述和现有研究的综合对TEER在严重的额头肌吐.
- 分析了额头膜面积减少和传导梯度增加之间的关系.
- 讨论临床结果,包括死亡率和心力衰竭住院率.
主要成果:
- TEER可以有效地减少严重的MR,但可能导致传导梯度显著增加.
- 剩余MR和传导梯度之间的最佳平衡尚未完全确定.
- 后TEER升高梯度对患者存活率和住院治疗的长期影响是正在进行的研究和辩论的主题.
结论:
- 需要仔细考虑,以权衡MR减少的好处与升高的传导梯度的风险.
- 为了充分了解TEER后传播梯度的长期临床意义,需要进行进一步的研究.
- 优化TEER技术和患者选择对于改善长期结果至关重要.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


